Ironwood Pharmaceuticals (IRWD) Total Debt Growth (1y) (2014 - 2026)
Ironwood Pharmaceuticals (IRWD) Total Debt Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | -3.69% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 37.49% |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -2.48% |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 4.38% |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | -6.91% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 41.53% |
| 10 | Ironwood Pharmaceuticals | 676.53 Mn | 597.40 Mn | - | -34.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -34.11% |
| Mar 31, 2026 | 51.91% |
| Dec 31, 2025 | 51.86% |
| Sep 30, 2025 | 46.13% |
| Jun 30, 2025 | 37.49% |
| Mar 31, 2025 | -18.91% |
| Dec 31, 2024 | -22.93% |
| Sep 30, 2024 | -23.71% |
| Jun 30, 2024 | -29.06% |
| Jun 30, 2019 | -36.34% |
| Mar 31, 2019 | -33.51% |
| Dec 31, 2018 | -31.64% |
| Sep 30, 2018 | -55.83% |
| Jun 30, 2018 | -23.72% |
| Mar 31, 2018 | -15.58% |
| Dec 31, 2017 | 0.45% |
| Sep 30, 2017 | 67.91% |
| Jun 30, 2017 | 43.33% |
| Mar 31, 2017 | 28.82% |
| Dec 31, 2016 | 10.17% |